CalciMedica (CALC) Assets (QoQ) (2020 - 2026)
CalciMedica (CALC) Assets (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | CalciMedica | 9.92 Mn | -8.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126.54% |
| Mar 31, 2026 | -36.66% |
| Dec 31, 2025 | -8.86% |
| Sep 30, 2025 | -21.84% |
| Jun 30, 2025 | -24.72% |
| Mar 31, 2025 | 28.05% |
| Dec 31, 2024 | 22.09% |
| Sep 30, 2024 | -22.99% |
| Jun 30, 2024 | -22.41% |
| Mar 31, 2024 | 122.68% |
| Dec 31, 2023 | -23.10% |
| Sep 30, 2023 | -21.73% |
| Jun 30, 2023 | -41.60% |
| Mar 31, 2023 | 935.20% |
| Dec 31, 2022 | -92.62% |
| Sep 30, 2022 | -16.03% |
| Jun 30, 2022 | -10.83% |
| Mar 31, 2022 | -12.31% |
| Dec 31, 2021 | -9.85% |
| Sep 30, 2021 | -7.47% |